Clinical Trial Update: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cyclophosphamide versus methotrexate for remission maintenance in systemic necrotizing vasculitides. The current trial status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Polyarteritis Nodosa

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Parma | Conditions: Wegener's Granulomatosis, Churg-Strauss Syndrome | Phase 2 | Status: UNKNOWN